OncoSec Announces Pricing of $3.5 Million Public Offering
November 30, 2022
Cannabics Pharmaceuticals Files a PCT Patent Application for Proprietary Cancer Treatment Formulations
May 11, 2021
Related Post
-
-
Item 9 Labs Corp. Appoints Mike Weinberger to CEO Ahead of Approaching Transformational Acquisition
November 30, 2022
-
First Wave BioPharma Files Investigational New Drug Application for Enhanced Microgranule Delivery Formulation of Adrulipase
November 30, 2022
-
Endexx Surpasses Record Annual Revenues in Fiscal First Quarter 2023
November 30, 2022